Login to My NLA Account

all

Sep, 2021

The National Lipid Association would like to extend its congratulations to all of our Fellows of the NLA, current and past, honored at the 2023 National Lipid Association Honors & Awards Ceremony earlier this month:

 

Cindy L. Bredefeld, DO, FNLA

Jaime Burkle, MD, FNLS

Joette Hughes, MSN, CRNP, CLS, FNLA

Sabyasachi Sen, MD, FNLA

0
No votes yet
Sep, 2021
The main goal of lipid testing is accurate identification of persons at high risk for ASCVD and the relevant science continues to evolve. Methods used to measure or calculate LDL-C from conventional lipid measurements are likely to be refined. Specialized evaluations of atherogenic lipid levels are generally not needed to assess patients prior to the initiation of aggressive lipid altering therapy.

0
No votes yet
Aug, 2021

The U.S. Food and Drug Administration released a Drug Safety Communication on July 20, 2021, concerning the removal of the strongest warning against using statins during pregnancy. The warning states that statins should never be used in any patients during pregnancy.

0
No votes yet